Plain-English translation of NCT06794372 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial evaluates a new imaging technique called that uses a special radioactive tracer to highlight cancer cells and help doctors see if cancer has spread to nearby lymph nodes. The scan combines two types of imaging — one that shows how cells are behaving and one that shows anatomy — to give doctors a clearer picture of your cancer before surgery.
Current imaging methods don't always detect when cancer has spread to lymph nodes, which can affect treatment planning and outcomes. This trial tests whether this new medication can find cancer spread more accurately and help surgeons plan better surgery.
You likely qualify if…
You likely don't qualify if…
You will receive an injection of the radioactive tracer through an IV line. About one hour later, you'll have a PET/CT scan that takes approximately 20 minutes — during which you'll lie still on a table as the scanner creates detailed images of your body. This scan will be done before your scheduled surgery as part of your regular cancer evaluation.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Switzerland